Skip to main content

Table 1 Nucleocapsid protein-derived peptides selected for SISCAPA assays and their transitions

From: A SISCAPA-based approach for detection of SARS-CoV-2 viral antigens from clinical samples

Peptide

Position

m/z

Charge

Selected transitions

NPANNAAIVLQLPQGTTLPK

150–169

687.388

3

y10, y9, y8, y7, y6

DGIIWVATEGALNTPK

128–143

842.948

2

y12, y11, y10, y9, y7

ITFGGPSDSTGSNQNGER

15–32

912.411

2

y13, y11, y10, y9, y8